- Home
- HRZN vs ABEO Comparison
HRZN vs ABEO Comparison
Compare HRZN & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRZN
- ABEO
- Stock Information
- Founded
- HRZN 2008
- ABEO 1974
- Country
- HRZN United States
- ABEO United States
- Employees
- HRZN N/A
- ABEO N/A
- Industry
- HRZN Finance/Investors Services
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- HRZN Finance
- ABEO Health Care
- Exchange
- HRZN Nasdaq
- ABEO Nasdaq
- Market Cap
- HRZN 295.3M
- ABEO 332.0M
- IPO Year
- HRZN 2010
- ABEO 1980
- Fundamental
- Price
- HRZN $6.90
- ABEO $6.83
- Analyst Decision
- HRZN Hold
- ABEO Strong Buy
- Analyst Count
- HRZN 4
- ABEO 6
- Target Price
- HRZN $7.81
- ABEO $18.17
- AVG Volume (30 Days)
- HRZN 667.7K
- ABEO 695.3K
- Earning Date
- HRZN 08-07-2025
- ABEO 08-14-2025
- Dividend Yield
- HRZN 19.16%
- ABEO N/A
- EPS Growth
- HRZN N/A
- ABEO N/A
- EPS
- HRZN N/A
- ABEO 0.99
- Revenue
- HRZN $97,144,000.00
- ABEO $400,000.00
- Revenue This Year
- HRZN $0.51
- ABEO N/A
- Revenue Next Year
- HRZN $9.90
- ABEO $339.63
- P/E Ratio
- HRZN N/A
- ABEO $6.91
- Revenue Growth
- HRZN N/A
- ABEO N/A
- 52 Week Low
- HRZN $6.77
- ABEO $3.93
- 52 Week High
- HRZN $11.15
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- HRZN 30.61
- ABEO 52.71
- Support Level
- HRZN $6.86
- ABEO $6.70
- Resistance Level
- HRZN $6.96
- ABEO $7.15
- Average True Range (ATR)
- HRZN 0.09
- ABEO 0.31
- MACD
- HRZN -0.00
- ABEO -0.02
- Stochastic Oscillator
- HRZN 15.00
- ABEO 46.62
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.